Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6087]

European Commission approves lazertinib in combination with amivantamab for the first-line treatment of patients with EGFR-mutated advanced NSCLC

European Commission approves lazertinib in combination with amivantamab for the first-line treatment of patients...

FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer

FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer

Phase 2 LITESPARK-003 results suggest continued study of novel first-line combo for advanced kidney cancer

Phase 2 LITESPARK-003 results suggest continued study of novel first-line combo for advanced kidney cancer

Research identifies new cause of chemotherapy resistance in triple-negative breast cancer

Research identifies new cause of chemotherapy resistance in triple-negative breast cancer

FDA approves sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

FDA approves sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma

FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma

Bile acids exacerbate liver cancer, dietary supplement may offer relief

Bile acids exacerbate liver cancer, dietary supplement may offer relief

Immunotherapy against cancer: How therapeutic antibodies do their job

Immunotherapy against cancer: How therapeutic antibodies do their job

Lung cancer test predicts survival in early stages better than current methods

Lung cancer test predicts survival in early stages better than current methods

Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer

Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy...

More from ecancer